Clifford Chance and Webber Wentzel advised DP World on the deal. DP World proposed the acquisition (by way of scheme of arrangement) of JSE-listed Imperial Logistics, a...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Parsons Corporation in the transaction. Parsons Corporation (NYSE:PSN) entered into a definitive agreement to acquire BlackHorse Solutions, Inc. in an accretive deal...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented eFFECTOR in the transaction, eFFECTOR Therapeutics, Inc. (eFFECTOR), a biopharmaceutical company focused on pioneering the development of selective translation regulation inhibitors...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP and and Greenberg Traurig, LLP represented the Tribe in the transaction. The San Manuel Band of Mission Indians (San Manuel or the...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Icosavax, Inc. in the transaction. Icosavax, Inc. closed a US$100 million Series B Financing, led by RA Capital Management and joined by...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP and Maples and Calder represented Connect Biopharma in the transaction. Global Law Office and Davis Polk advised joint book-running managers. Connect Biopharma...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented the underwriters in the offering. Longboard Pharmaceuticals, Inc. closed its initial public offering of 5 million shares of its common stock at...
You must be a Standard 1 Year member to access this content.
